This is a Phase 3 study of AVB-S6-500 in combination with paclitaxel (Pac) in patients with platinum resistant recurrent ovarian cancer. This is a randomized, double-blind, placebo-controlled study to compare efficacy and tolerability of AVB-S6-500 in combination with Pac versus placebo plus Pac.
Check your eligibility (clinicaltrials.gov)
Participate in a Clinical Trial at Saint John’s Cancer Research Institute.
Questions regarding this trial: 818-748-4772